We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$3.61B
AUM Growth
-$151M
Cap. Flow
-$239M
Cap. Flow %
-6.63%
Top 10 Hldgs %
78.3%
Holding
307
New
3
Increased
130
Reduced
84
Closed
19

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$4.43M
2
UNH icon
UnitedHealth
UNH
+$2.97M
3
LOW icon
Lowe's Companies
LOW
+$2.31M
4
UBER icon
Uber
UBER
+$2.15M
5
META icon
Meta Platforms (Facebook)
META
+$1.95M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$61.2M
2
BSX icon
Boston Scientific
BSX
+$44.9M
3
IT icon
Gartner
IT
+$12.9M
4
AMZN icon
Amazon
AMZN
+$10.5M
5
LLY icon
Eli Lilly
LLY
+$9.63M

Sector Composition

Rank Sector Weight
1 Healthcare 57.96%
2 Technology 8.83%
3 Energy 7.82%
4 Consumer Discretionary 4.91%
5 Utilities 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
26
Merck
MRK
$321B
$15.5M 0.43%
155,970
-28,509
-15% -$2.94M
ET icon
27
Energy Transfer Partners
ET
$69.6B
$14.3M 0.4%
729,590
-24,128
-3% -$427K
COP icon
28
ConocoPhillips
COP
$145B
$12.5M 0.35%
126,123
-3,264
-3% -$347K
PSX icon
29
Phillips 66
PSX
$84.4B
$11.8M 0.33%
103,472
-721
-0.7% -$91.7K
ENB icon
30
Enbridge
ENB
$121B
$10.5M 0.29%
246,616
+9,213
+4% +$386K
V icon
31
Visa
V
$684B
$10.3M 0.29%
32,723
+14,721
+82% +$4.43M
ABT icon
32
Abbott
ABT
$183B
$9.66M 0.27%
85,437
-15,185
-15% -$1.75M
JNJ icon
33
Johnson & Johnson
JNJ
$617B
$9.2M 0.26%
63,634
-12,836
-17% -$1.99M
QQQ icon
34
Invesco QQQ Trust
QQQ
$450B
$8.94M 0.25%
17,496
+50
+0.3% +$25.3K
PM icon
35
Philip Morris
PM
$299B
$8.92M 0.25%
74,138
+873
+1% +$110K
BP icon
36
BP
BP
$114B
$8.74M 0.24%
295,712
-8,446
-3% -$254K
LOW icon
37
Lowe's Companies
LOW
$118B
$8.37M 0.23%
33,913
+8,647
+34% +$2.31M
FE icon
38
FirstEnergy
FE
$28.2B
$8.09M 0.22%
203,432
-533
-0.3% -$22.3K
BAC icon
39
Bank of America
BAC
$433B
$7.75M 0.21%
176,255
-42,679
-19% -$1.88M
DINO icon
40
HF Sinclair
DINO
$16.7B
$7.34M 0.2%
209,445
-7,247
-3% -$296K
VOO icon
41
Vanguard S&P 500 ETF
VOO
$972B
$7.1M 0.2%
13,175
+77
+0.6% +$41.7K
VLO icon
42
Valero Energy
VLO
$92.6B
$6.91M 0.19%
56,362
-1,714
-3% -$229K
NVDA icon
43
NVIDIA
NVDA
$4.72T
$6.79M 0.19%
50,598
-7,497
-13% -$1.03M
BMY icon
44
Bristol-Myers Squibb
BMY
$132B
$6.77M 0.19%
119,678
-935
-0.8% -$52.2K
FTS icon
45
Fortis
FTS
$29.3B
$6.38M 0.18%
153,504
-3,056
-2% -$134K
KMB icon
46
Kimberly-Clark
KMB
$36.6B
$6.27M 0.17%
47,814
-1,980
-4% -$270K
GS icon
47
Goldman Sachs
GS
$302B
$6.15M 0.17%
10,734
-2,145
-17% -$1.2M
UNH icon
48
UnitedHealth
UNH
$383B
$6.09M 0.17%
12,049
+5,221
+76% +$2.97M
PLD icon
49
Prologis
PLD
$136B
$5.81M 0.16%
54,992
-3,066
-5% -$352K
NDAQ icon
50
Nasdaq
NDAQ
$53.2B
$5.58M 0.15%
72,248
+218
+0.3% +$16.9K

Similar funds

Bollard Group's Q4 2024 Portfolio in Review

As of Q4 2024, Bollard Group held 307 positions worth $3.61B, down 4% from $3.76B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bollard Group withdrew a net $239M in Q4 2024, closing 19 positions and reducing 84 holdings. Its most notable exit was Fidelity High Dividend ETF, an estimated $7.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 57% a quarter earlier, followed by Technology and Energy.

Against the trend, Bollard Group opened a new position in Celestica worth $65K.

  • Bollard Group's largest Q4 2024 buy was Celestica: 700 shares worth $65K.
  • Bollard Group added most to Visa in Q4 2024, an estimated $4.43M increase.
  • Bollard Group's biggest Q4 2024 reduction was Thermo Fisher Scientific, cutting an estimated $61.2M.
  • Bollard Group fully exited Fidelity High Dividend ETF in Q4 2024, selling an estimated $7.04M.
  • Bollard Group's ten largest holdings make up 78% of its $3.61B portfolio in Q4 2024.
  • Bollard Group opened 3 new positions and closed 19 in Q4 2024.
  • Bollard Group's portfolio value fell 4% quarter-over-quarter to $3.61B.

Based on Bollard Group's 13F filing for Q4 2024, filed 14 Feb 2025.